Page last updated: 2024-10-24

positive regulation of interleukin-33 production

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate or extent of interleukin-33 production. [GOC:aruk]

Positive regulation of interleukin-33 (IL-33) production is a complex biological process involving multiple signaling pathways and cellular mechanisms. IL-33 is a member of the IL-1 cytokine family, primarily known for its role in the initiation and amplification of type 2 immune responses. Its production is tightly regulated, ensuring appropriate activation of immune cells in response to specific stimuli.

**Stimuli and Cellular Sources:**

* **Inflammatory signals:** TLRs (Toll-like receptors), particularly TLR4, are activated by bacterial products like lipopolysaccharide (LPS), triggering downstream signaling pathways that promote IL-33 production.
* **Stress-related signals:** Cellular stress, such as hypoxia, oxidative stress, or DNA damage, can induce IL-33 production.
* **Immune cell activation:** Activation of specific immune cells, like macrophages or dendritic cells, can lead to IL-33 expression.

**Signaling Pathways:**

* **NF-κB pathway:** TLRs activate the NF-κB signaling pathway, leading to the transcription of IL-33 gene.
* **MAPK pathway:** MAPK kinases, such as ERK, JNK, and p38, are also involved in IL-33 production by mediating phosphorylation events and transcription factor activation.
* **STAT pathway:** The STAT pathway, activated by cytokines like IFN-γ, can also influence IL-33 expression.

**Cellular Mechanisms:**

* **Transcriptional regulation:** IL-33 expression is tightly controlled by transcription factors, including NF-κB, AP-1, and STATs.
* **Post-transcriptional regulation:** IL-33 mRNA stability is influenced by microRNAs and RNA-binding proteins.
* **Post-translational modifications:** IL-33 can undergo post-translational modifications like glycosylation, which may affect its activity.

**Regulation and Release:**

* **IL-33 is primarily found in its precursor form, pro-IL-33, within cells.**
* **Upon stimulation, pro-IL-33 is cleaved by caspase-1 or caspase-8, generating the mature, active form of IL-33.**
* **Mature IL-33 is then released from cells, either by passive diffusion or active secretion.**

**Biological Consequences:**

* **IL-33 plays a crucial role in the initiation and amplification of type 2 immune responses.**
* **It activates group 2 innate lymphoid cells (ILC2s) and mast cells, leading to the production of type 2 cytokines like IL-5 and IL-13.**
* **IL-33 also contributes to the development of allergic inflammation and asthma.**

**Overall, positive regulation of IL-33 production is a complex process involving multiple signaling pathways, cellular mechanisms, and regulatory factors. This tight control ensures appropriate activation of immune cells in response to specific stimuli, while also contributing to the development of various inflammatory conditions.**'
"

Proteins (1)

ProteinDefinitionTaxonomy
Tumor necrosis factorA tumor necrosis factor that is encoded in the genome of human. [PRO:DNx]Homo sapiens (human)

Compounds (18)

CompoundDefinitionClassesRoles
mesalaminemesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
amino acid;
aromatic amine;
monocarboxylic acid;
monohydroxybenzoic acid;
phenols
non-steroidal anti-inflammatory drug
way 151693
pentoxifyllineoxopurine
4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.methoxybenzenes
roliprampyrrolidin-2-onesantidepressant;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
sulfasalazinesulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
bergeninbergenin: RN refers to (2R-(2alpha,3beta,4alpha,4aalpha,10bbeta))-isomer; structuretrihydroxybenzoic acidmetabolite
marimastatmarimastat : A secondary carboxamide resulting from the foraml condensation of the carboxy group of (2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the alpha-amino group of N,3-dimethyl-L-valinamide.

marimastat: a matrix metalloproteinase inhibitor active in patients with advanced carcinoma of the pancreas, prostate, or ovary
hydroxamic acid;
secondary carboxamide
antineoplastic agent;
matrix metalloproteinase inhibitor
birb 796aromatic ether;
morpholines;
naphthalenes;
pyrazoles;
ureas
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
immunomodulator
ganoderic acid atriterpenoid
ganoderiol fganoderiol F: a ganoderma triterpene from Ganoderma amboinense; structure in first sourcetriterpenoid
1-(phenylmethyl)benzimidazolebenzimidazoles
luteolin-7-glucosideluteolin 7-O-beta-D-glucoside : A glycosyloxyflavone that is luteolin substituted by a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.

luteolin-7-glucoside: has both antiasthmatic and antineoplastic activities; has 3C protease inhibitory activity; isolated from Ligustrum lucidum
beta-D-glucoside;
glycosyloxyflavone;
monosaccharide derivative;
trihydroxyflavone
antioxidant;
plant metabolite
apigetrinapigenin 7-O-beta-D-glucoside : A glycosyloxyflavone that is apigenin substituted by a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.

apigetrin: structure given in first source
beta-D-glucoside;
dihydroxyflavone;
glycosyloxyflavone;
monosaccharide derivative
antibacterial agent;
metabolite;
non-steroidal anti-inflammatory drug
calycosin-7-o-beta-d-glucopyranosidecalycosin-7-O-beta-D-glucoside : A glycosyloxyisoflavone that is calycosin substituted by a beta-D-glucopyranosyl residue at position at 7 via a glycosidic linkage.

calycosin-7-O-beta-D-glucoside: from Radix Astragali
4'-methoxyisoflavones;
7-hydroxyisoflavones 7-O-beta-D-glucoside;
hydroxyisoflavone;
monosaccharide derivative
spd-304SPD-304: structure in first source
ganoderic acid fganoderic acid F: isolated from Ganoderma lucidum; structure in first sourcetriterpenoid
ganoderic acid c2ganoderic acid C2: from the fruiting body of Ganoderma; structure in first sourcetriterpenoid